Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer

Author： Cho Yo   Kim Sung   Hong Lee M.   Yoo Moon-Won   Bang Ho-Yoon   Lee Kyung-Yung   Yoon So  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.15, Iss.4, 2012-10, pp. : 389-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Irinotecan, leucovorin and 5fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 751-754

Spandidos Publications

Access to resources Recommend Favorite

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

By                          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 425-428

Spandidos Publications

Access to resources Recommend Favorite

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

By Pernot Simon   Mitry Emmanuel   Samalin Emmanuelle   Dahan Laetitia   Dalban Cécile   Ychou Marc   Seitz Jean-François   Turki Hajer   Mazard Thibault   Zaanan Aziz   Lepère Céline   Vaillant Jean-Nicolas   Landi Bruno   Rougier Philippe   Taieb Julien  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 341-347

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer

By Lin Peng-Chan   Chen Wei-Shone   Chao Ta-Chung   Yang Shung-Haur   Tiu Chui-Mei   Liu Jin-Hwang  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 351-356

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

By Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 336-341

Informa Healthcare

Access to resources Recommend Favorite